Evidence map›Paper›PMID 39208369›Full record

ArticleBlood advances2024

NFAT5 counters long-term IFN-1 responses in hematopoietic stem cells to preserve reconstitution potential.

Laia Traveset, Víctor Cerdán Porqueras, Hector Huerga Encabo, Silvia Avalle, Anna Esteve-Codina, Oscar Fornas, Jose Aramburu, Cristina Lopez-Rodriguez

Abstract read
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laia TravesetDepartment of Medicine and Life Sciences, Immunology Unit, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0003-1588-5035
Víctor Cerdán PorquerasDepartment of Medicine and Life Sciences, Immunology Unit, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0002-3711-0057
Hector Huerga EncaboDepartment of Medicine and Life Sciences, Immunology Unit, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0002-3723-8624
Silvia AvalleDepartment of Medicine and Life Sciences, Immunology Unit, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0009-0007-8384-7264
Anna Esteve-CodinaBioinformatics unit, Centro Nacional de Análisis Genómico, Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain.ORCID 0000-0003-0361-2873
Oscar FornasDepartment of Medicine and Life Sciences, Flow Cytometry Unit, Universitat Pompeu Fabra, Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain.ORCID 0000-0003-2017-9100
Jose AramburuDepartment of Medicine and Life Sciences, Immunology Unit, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0001-9279-9523
Cristina Lopez-RodriguezDepartment of Medicine and Life Sciences, Immunology Unit, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0002-2311-2406

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractHematopoietic stem cells (HSCs) readily recover from acute stress, but persistent stress can reduce their viability and long-term potential. Here, we show that the nuclear factor of activated T cells 5 (NFAT5), a transcription modulator of inflammatory responses, protects the HSC pool under stress. NFAT5 restrains HSC differentiation to multipotent progenitors after bone marrow transplantation and bone marrow ablation with ionizing radiation or chemotherapy. Correspondingly, NFAT5-deficient HSCs fail to support long-term reconstitution of hematopoietic progenitors and mature blood cells after serial transplant. Evidence from competitive transplant assays shows that these defects are HSC intrinsic. NFAT5-deficient HSCs exhibit enhanced expression of type 1 interferon (IFN-1) response genes after transplant, and suppressing IFN-1 receptor prevents their exacerbated differentiation and cell death after reconstitution and improves long-term regeneration potential. Blockade of IFN-1 receptor also prevented the overdifferentiation of NFAT5-deficient HSCs after bone marrow ablation. These findings show that long-term IFN-1 responses to different hematopoietic stressors drive HSCs toward more differentiated progenitors, and that NFAT5 has an HSC-intrinsic role, limiting IFN-1 responses to preserve reconstitution potential. Our identification of cell-intrinsic mechanisms that strengthen the resistance of HSCs to stress could help to devise approaches to protect long-term stemness during the treatment of hematopoietic malignancies.

Indexed as

Hematopoietic Stem CellsTranscription FactorsAnimalsCell DifferentiationHematopoietic Stem Cell TransplantationInterferon Type IMiceMice, KnockoutInterferon Type INfat5 protein, mouseTranscription Factors

Identifiers

PMID39208369
PMCPMC11538617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.